Lipocine Inc (LPCN)

[gi197845]

Ok, please screen for accuracy and fill the blanks, so to recap, the basic view on this is...

In 2018, there should not be a need for a reverse split or a secondary offering with warrants to raise money, because Lipocine already secured a 10 million dollar loan, in January 2018...

We are waiting for FDA clarification on TLando, but at this point, there does not appear to be a need for another complete TLando test with different tubes and that this could be FDA confirmed within the next couple of months...

All it should seem to take for TLando to get FDA approval, is to redo the ambulatory blood pressure effects study, to hopefully prove that in vivo conversion does not happen, which if agreed to, is sort of a cataylst...

The next catalyst, could be good, confirmation news from the FDA that, only the ABPM study needs to be redone, which would only take a couple of months and perhaps, just result in FDA approval, with a black-label warning?

Another catalyst could be that Lipocene announces a partner to market the pre term birth pill, which in theory should easily receive FDA approval.

(The FDA appears to be gyno-centric and approves just about anything to improve the life of females, just as universities and mass media and the workforce have become gyno-centric as well.)

After TLando approves FDA approval, the once per day TLando pill (I don't know what its' called) should be tested in phase I,II,III with already knowing the proper testing protocol, taking into account blood pressure and different tubes???

Maybe the Lipocine will drop the 3 per day TLando pill which is dependent on meals/calories to function and just concentrate on the 1 per day T pill, which apparently is not dependent on meals/calories?